This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2004 Jul 8;351(2):185-7.

doi: 10.1056/NEJMcibr041466.

Sparking the failing heart

Maryjane A Farr¹, Craig T Basson

Affiliations

Affiliation

¹ Molecular Cardiology Laboratory and Congestive Heart Failure Center, Greenberg Cardiology Division, Department of Medicine, Weill Medical College of Cornell University, New York, USA.

PMID: 15247360
DOI: 10.1056/NEJMcibr041466

Sparking the failing heart

Maryjane A Farr et al. N Engl J Med. 2004.

. 2004 Jul 8;351(2):185-7.

doi: 10.1056/NEJMcibr041466.

Authors

Maryjane A Farr¹, Craig T Basson

Affiliation

¹ Molecular Cardiology Laboratory and Congestive Heart Failure Center, Greenberg Cardiology Division, Department of Medicine, Weill Medical College of Cornell University, New York, USA.

PMID: 15247360
DOI: 10.1056/NEJMcibr041466

No abstract available

PubMed Disclaimer

Similar articles

Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.
Wehrens XH, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR. Wehrens XH, et al. Science. 2004 Apr 9;304(5668):292-6. doi: 10.1126/science.1094301. Science. 2004. PMID: 15073377
Treatment of heart failure through stabilization of the cardiac ryanodine receptor.
Hasenfuss G, Seidler T. Hasenfuss G, et al. Circulation. 2003 Jan 28;107(3):378-80. doi: 10.1161/01.cir.0000046342.46135.cb. Circulation. 2003. PMID: 12551857 No abstract available.
A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure.
Kohno M, Yano M, Kobayashi S, Doi M, Oda T, Tokuhisa T, Okuda S, Ohkusa T, Kohno M, Matsuzaki M. Kohno M, et al. Am J Physiol Heart Circ Physiol. 2003 Mar;284(3):H1035-42. doi: 10.1152/ajpheart.00722.2002. Epub 2002 Nov 14. Am J Physiol Heart Circ Physiol. 2003. PMID: 12433661
Novel therapeutic approaches for heart failure by normalizing calcium cycling.
Wehrens XH, Marks AR. Wehrens XH, et al. Nat Rev Drug Discov. 2004 Jul;3(7):565-73. doi: 10.1038/nrd1440. Nat Rev Drug Discov. 2004. PMID: 15232578 Review. No abstract available.
Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention-An in vivo perspective.
Currie S, Elliott EB, Smith GL, Loughrey CM. Currie S, et al. Pharmacol Ther. 2011 Aug;131(2):204-20. doi: 10.1016/j.pharmthera.2011.02.006. Epub 2011 Mar 15. Pharmacol Ther. 2011. PMID: 21414358 Review.

See all similar articles

Cited by

Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.
van Oort RJ, McCauley MD, Dixit SS, Pereira L, Yang Y, Respress JL, Wang Q, De Almeida AC, Skapura DG, Anderson ME, Bers DM, Wehrens XH. van Oort RJ, et al. Circulation. 2010 Dec 21;122(25):2669-79. doi: 10.1161/CIRCULATIONAHA.110.982298. Epub 2010 Nov 15. Circulation. 2010. PMID: 21098440 Free PMC article.
Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction.
Cho JH. Cho JH. Korean Circ J. 2022 Apr;52(4):251-264. doi: 10.4070/kcj.2021.0420. Korean Circ J. 2022. PMID: 35388994 Free PMC article. Review.
Structural determination of the phosphorylation domain of the ryanodine receptor.
Sharma P, Ishiyama N, Nair U, Li W, Dong A, Miyake T, Wilson A, Ryan T, MacLennan DH, Kislinger T, Ikura M, Dhe-Paganon S, Gramolini AO. Sharma P, et al. FEBS J. 2012 Oct;279(20):3952-64. doi: 10.1111/j.1742-4658.2012.08755.x. Epub 2012 Sep 11. FEBS J. 2012. PMID: 22913516 Free PMC article.
Role of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease.
Dobrev D, Wehrens XH. Dobrev D, et al. Circ Res. 2014 Apr 11;114(8):1311-9; discussion 1319. doi: 10.1161/CIRCRESAHA.114.300568. Circ Res. 2014. PMID: 24723656 Free PMC article.
Prolonged action potential duration in cardiac ablation of PDK1 mice.
Han Z, Jiang Y, Yang Z, Cao K, Wang DW. Han Z, et al. Int J Clin Exp Med. 2015 Apr 15;8(4):5485-91. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131127 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information